TNFSF12 and central nervous system cancer: Altogether, these data suggest that blocking TWEAK signaling and noncanonical NF-κB activation, alone or in combination with inhibition of canonical NF-κB signaling, will be more efficacious for attenuation of tumor cell invasion and, therefore, have therapeutic value in a broad range of glioma subtypes.